Francesca Baldinetti

Francesca Baldinetti

Company: Novartis Gene Therapies

Job title: Executive Medical Director, Gene Therapy, EMEA


Confirming the Value of Gene Therapies Through Real-World Data – From Accelerated Approval to Proven Long-Term Outcomes 9:30 am

Making gene therapies quickly available for patients through accelerated approvals based on limited clinical data Post-approval real-world evidence (RWE) seeks to characterise safety and efficacy parameters in clinical practice and in the long term Using RWE to underline the value proposition and sustained benefit of gene therapy for patients and familiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.